This Week in Psychedelics - 1.14.22

Cannabis

• Oregon State research shows hemp compounds prevent coronavirus from entering human cells (Oregon State University)

• Polls Funded By Marijuana Prohibitionist Group Show Big Support For Legalization Policies It Lobbies Against (Marijuana Moment)

• Top German Government Official Previews Marijuana Legalization Plan Details (Marijuana Moment)

• First-dose vaccinations quadruple in Quebec ahead of restrictions at liquor and cannabis stores (CTV News)

• Mississippi Senate Votes To Legalize Medical Marijuana, Defying Governor’s Veto Threat (Marijuana Moment)

• Oregon: New Rules Increase the Amount of Cannabis Adults Can Purchase Per Transaction (NORML)

• Ohio Marijuana Activists Turn In More Signatures For Legalization Initiative After Temporary Setback (Marijuana Moment)

• Delaware Lawmakers File New Marijuana Legalization Bill With Key Equity Revisions (Marijuana Moment)

• Kansas lawmaker wants to refer medical marijuana legalization to voters (Marijuana Business Daily)

• Austin Officials Certify Local Marijuana Decriminalization Initiative For May Ballot (Marijuana Moment)

• Wyoming Activists Prepare Cannabis Reform Initiatives (High Times)

• Virginia Lawmakers Divided On Releasing Marijuana Prisoners Following Legalization Taking Effect (Marijuana Moment)

• South Dakota Governor Wants Marijuana Activists To Pay Legal Bill For Her Lawsuit That Blocked Legalization (Marijuana Moment)

• Florida Marijuana Activists Pivot To 2024 For Legalization Ballot Initiative (Marijuana Moment)

Magic Mushrooms

• Global Coalition Launches Push To Reschedule Psilocybin Under International Rules (Marijuana Moment)

• Italian Officials Certify Signatures For National Marijuana And Psilocybin Referendum (Marijuana Moment)

• Rollups: The Emerging Magic Mushroom Monopoly (The American Prospect)

• Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary Psilocybin Product (Psilocybin Alpha)

• Psilocybin Clinical Trial for Depression Launches at Pacific Neuroscience Institute (PR Newswire)

MDMA

• MAPS Publishes Open Science Approach to Synthesizing MDMA (Lucid News)

Ayahuasca

• A New Study Attempts To Quantify The Healing Powers Of Ayahuasca (Forbes)

Novel Psychoactive Substances

• Mydecine Achieves Innovative Supercomputing Artificial Intelligence Modeling in Psychedelic Drug Development Enabling Quick Screening of Billions of Compounds (Psilocybin Alpha)

• Field Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in Development (Psilocybin Alpha)

Ketamine

• Trial of Ketamine Therapy for Alcohol Use Disorder Reports Positive Findings (Technology Networks)

• Osmind Announces Publication of the Largest Real-World Analysis of Ketamine Infusion Therapy for Depression (Business Wire)

• Institutional Review Board Grants Approval for Cybin-Sponsored Feasibility Study Using Kernel Flow Technology to Measure Psychedelic Effects on the Brain (Psilocybin Alpha)

• Peter Thiel-Backed Psychedelics Company Gets FDA Approval To Study Ketamine Therapy (Forbes)

• PharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for Ketamine to Treat ALS (Psilocybin Alpha)

Miscellaneous

• How Beer and Drugs Empowered an Ancient Andean Empire (Gizmodo)

• These States Could Legalize Marijuana Or Psychedelics In 2022 (Marijuana Moment)

• Virginia Could Decriminalize Psilocybin And Other Psychedelics With Newly Filed Bills (Marijuana Moment)

• Social Media Attacks and Ethical Issues in the Psychedelic Sector — Why can’t we all get on together for the greater good? (Medium)

• Missouri Patients Could Use Psychedelic Treatments Under New GOP ‘Right-To-Try’ Bill (Marijuana Moment)

• ‘Microdosers’ of LSD and magic mushrooms are wiser and more creative (Daily Maverick)

• Promising Psychedelic Therapy Legislation Set to Make Waves in 2022 (Psychedelic Spotlight)

• Vermont Lawmakers File Drug Decriminalization Bill With Hopes Of Promoting Harm Reduction (Marijuana Moment)

• Announcing a Major Healthy Persons Trial to Investigate the Brain Activity Effects of Psychedelic Medicines (Mind Medicine Australia)

• University Of Ottawa To Offer Psychedelic Studies Master’s Program Beginning In Fall 2022 (Healing Maps)

• The Connection between Psychedelics and Christianity (The Institute for the Advancement of Psychedelic Christianity)

• Metaphysical Insight: Psychedelics, Noetic Experiences, and Spinoza’s God (Sam Woolfe)

• How to Come Out to Your Kids About Psychedelics (DoubleBlind)

• Psychedelics in Healthcare: The Psychedelic Pharmacists Association (Truffle Report)

• Can Western Medicine Include the Sacred in Psychedelic-Assisted Psychotherapy? (Lucid News)

• How To Vet Your Psychedelic Guide (DoubleBlind)

• Mydecine to Launch Special Access Support and Supply Program in Canada Expanding Access to Psychedelic-Assisted Psychotherapy For Patients (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 12.3.21

Cannabis

• Home of Dubai, the United Arab Emirates, Ends Jail Time for Travelers with THC (High Times)

• Mexico has a new marijuana legalization bill. Here’s what’s in it (Leafly)

• Reps. Dave Joyce and Alexandria Ocasio-Cortez Introduce Legislation To Expunge Marijuana Records (NORML)

• South Dakota's Governor Succeeds in Blocking Voter-Approved Marijuana Legalization (Reason)

• Fentanyl-laced vape pens among teens concern after Tennessee high school incident (WKYT)

• Record Number of Scientific Papers Published About Cannabis in 2021 (NORML)

• Death sentences upheld for two men convicted of cannabis trafficking (Singapore Law Watch)

• California rolls out plans to standardize cannabis testing statewide (Marijuana Business Daily)

• Jamaican Government Launches ‘Good Ganja Sense’ Campaign To Debunk Marijuana Myths (Marijuana Moment)

• Great News, Scientists Finally Figured Out Why Cannabis Smells 'Skunky' (ScienceAlert)

• Texas Activists Turn In Signatures To Put Marijuana Decriminalization On Austin’s 2022 Ballot (Marijuana Moment)

• Kentucky Lawmaker Pre-Files Marijuana Legalization Bills For 2022 Session (Marijuana Moment)

• Colorado University Announces Groundbreaking Study on Cannabis and Exercise (High Times)

• Massachusetts: Majority of Adults Say Marijuana Legalization Has Been “Positive” for the State (NORML)

LSD

• Blotter paper should be included while measuring weight of LSD, rules Bombay HC (India Today)

• How LSD changed The Beatles forever (Far Out Magazine)

Magic Mushrooms

• New Study Suggests SSRI Drugs Can Be Used Safely with Psilocybin to Treat Depression (Psychedelic Spotlight)

• Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress (Psilocybin Alpha)

• U of M Medical School launches new mechanistic study of psilocybin (University of Minnesota)

Ayahuasca

• Sexual Assault in the Amazon (The Cut)

Iboga

• Ibogaine and Cardiac Arrhythmia: The Heart of the Matter (Psychedelic Science Review)

Novel Psychoactive Substances

• MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation (Psilocybin Alpha)

• Bright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic Program for the Treatment of Mental Diseases (Psilocybin Alpha)

Nitrous Oxide

• ‘Everyone’s gagging for it’ – how Britain got high on nitrous oxide (The Guardian)

• Dozens of traffic accident deaths linked to laughing gas use (NL Times)

Ketamine

• Ketamine review: Chemical restraints may have been ‘disproportionately’ used on ‘communities of color’ (KDVR)

• As ketamine clinics emerge in Seattle to treat mental illness, so does debate about safety and regulations (The Seattle Times)

• PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent Portfolio (Psilocybin Alpha)

Miscellaneous

• New York City Opens First Safe Consumption Sites For Illegal Drugs In The U.S. (Marijuana Moment)

• Florida Lawmaker Files Bill To Decriminalize All Currently Illicit Drugs (Marijuana Moment)

• Toronto May Be the Next City to Decriminalize Psychedelics and Other Drugs (Truffle Report)

• Study Shows People Who Use Psychedelics Were Under Less Stress During Covid-19 Lockdowns (Forbes)

• DEA Again Boosts 2022 Production Goals For Psychedelics Like Psilocybin, MDMA and DMT (Marijuana Moment)

• People ‘microdosing’ psychedelics to improve wellbeing during pandemic, drug survey finds (The Independent)

• Psychedelics may have long-term impact treating depression, mental illness - study (The Jerusalem Post)

• Psychedelic Telemedicine Has Arrived. What Could Possibly Go Wrong? (VICE)

• The Psychedelic Renaissance Is Ushering In a New Genre Of Electronic Music — And With It, New Revenue Streams (Billboard)

• Holiday Gift Guide 2021: Gifts For The Psychedelic Explorer (Forbes)

• Can ethics and sexual abuse allegations create backlash and impact the current psychedelic renaissance? (Chacruna)

• Will the psychedelic revolution bypass people of color? (The Lens)

• Celebrities: Are They Helping or Harming the Psychedelic Movement? (Psychedelic Spotlight)

• Origin Therapeutics Portfolio Company Tripsitter has Commenced Trading on the Canadian Securities Exchange (GlobeNewswire)

• Peter Thiel-backed psychedelic start-up increases stake in Compass Pathways (CNBC)

• Microdosing Protocols: Microdosing Every Day vs. Every Other Day (DoubleBlind)

• Editor’s Choice Award 2021-Best Study on Psychedelics and Neurochemistry (Psychedelic Science Review)

• Novel Psychedelic Treatment Approach Bypasses Hallucinogenic Effects to Allow Widespread Adoption (Pharmacy Times)

• Israeli start up makes pharmaceuticals out of psychedelic flora (i24 News)

• Getting Ahead of the Psychedelics Supply Crunch (Truffle Report)

• Numinus Develops Proprietary Psychedelic Tests with New Toxicity and Potency Scans (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 7.9.21

Cannabis

• First Full-Service Marijuana Delivery App Launches On Apple Store Following Policy Change (Marijuana Moment)

• Delta-8-THC craze concerns chemists (Chemical and Engineering News)

• Federal Marijuana Trafficking Convictions Have Fallen Dramatically Following Enactment of Statewide Legalization Laws (NORML)

• Study: Cannabis farms not as thirsty as previously thought (Eureka Times-Standard)

• FBI Loosens Marijuana Employment Policy For Would-Be Agents (Marijuana Moment)

• Cannabis Use Associated With Increased Decision Making Skills (Green Entrepreneur)

• Sioux Tribe Is Opening South Dakota's First and Only Medical Cannabis Dispensary (MERRY JANE)

• Brazil Gains Ground on Medical Marijuana, in Defiance of Bolsonaro (Filter)

• Temple research finds that tweaking CBD may help it curb pain and opioid use in mice (The Philadelphia Inquirer)

• South Dakota Marijuana Activists Unveil Four Legalization Initiatives For 2022 Ballot, Pending Supreme Court Decision (Marijuana Moment)

• Study: Cannabis use may be associated with suicidality in young adults (The Highland County Times)

Magic Mushrooms

• Just One Dose of Magic Mushroom Compound Regrows Lost Brain Connections in Mice (ScienceAlert)

• Is This Peter Thiel–Backed Startup Trying to Monopolize the Astral Plane? (Mother Jones)

MDMA

• Director James Cameron was high on MDMA when he came up with key Terminator 2 character (Metro)

• One-third of MDMA tested at festivals actually 'dangerous' drug eutylone - KnowYourStuff (Newshub)

• My summer of love: ‘Under the spell of ecstasy, strangers went straight to limitless intimacy’ (The Guardian)

DMT

• Tripping On Your Lunch Break: Inside the Rise of Casual DMT Use (VICE)

• Microdosing DMT… Wait, That’s a Thing? (EntheoNation)

Ayahuasca

• A Brief Heritage of Ayahuasca Art (DoubleBlind)

Mescaline

• Mescaline Could Help Fight Addiction, Depression, PTSD, and Anxiety, Study Suggests (MERRY JANE)

• Mescaline is Resurgent (Yet Again) As a Potential Medicine (Lucid News)

• Is Mescaline A Key Component In The Future Of Medicine? XPhyto Aims To Find Out (Forbes)

Peyote

• Inside a Peyote Pilgrimage (The New York Times)

• Two Projects Seek to Change the Legal Status of Peyote and Mushrooms in Mexico (Chacruna)

Novel Psychoactive Substances

• Twenty Two Plus One: Sunrise αMT at Huangshan (Maps of the Mind)

• NSW Health issues urgent alert over 'potent hallucinogen' found in MDMA (Sky News)

Synthetic Cannabinoids

• Warning over dangerous synthetic cannabis batch as death probed (Radio New Zealand)

Ketamine

• Colorado ketamine bill signed into law, limits police influence on sedative’s use (KDVR)

• Portrayed As Date Rape Drug, Ketamine Is Removed from California Decrim Bill (Lucid News)

Miscellaneous

• Rhode Island Governor Signs Historic Bill Legalizing Safe Consumption Sites For Illicit Drugs (Marijuana Moment)

• Study suggests psychedelic users reframe “bad trips” into positive experiences through detailed narratives (PsyPost)

• Michael Pollan is Back with Mind-Bending Thoughts on Drugs, Ego Death, and the Healing Power of Plants (GQ)

• Third California City Seeks To Decriminalize Psychedelics (Marijuana Moment)

• Psychedelic Drugs Are Moving From The Fringes Of Medicine To The Mainstream (Forbes)

• Best Practices for Serious Psychonauts (Maps of the Mind)

• Psychedelic Motherhood: The Altered States of Birth (Chacruna)

• Tryptamine Patents: Explaining Deuterated Drug Analogs (Truffle Report)

• The Ritual: A Framework for Psychedelic Journeys (Maps of the Mind)

• Real-World Research in Psychedelic Science (Psychedelic Science Review)

• Keeping a Drug Journal (Maps of the Mind)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.22.21

Cannabis

• France launches public consultation on legalising cannabis (France24)

• UFC ditch marijuana ban but fighters warned to ‘temper enthusiasm’ after Usada rule change (The Independent)

• Biden Taps Marijuana Legalization Supporter To Lead Democratic National Committee (Marijuana Moment)

• American Medical Association Asks Court To Overturn Medical Marijuana Vote In Mississippi (Marijuana Moment)

• Arizona: Adult Use Marijuana Sales On Track to Begin This Month (NORML)

• This Michigan marijuana dispensary is giving free weed to anyone who got the COVID-19 vaccine (Detroit Metro Times)

• Trump Grants Clemency To Marijuana Prisoners On Last Day In Office (Marijuana Moment)

• Study: Nearly Half of Medical Cannabis Users Cease Using Opioids for Pain After Twelve Months (NORML)

• Congressman Files First Federal Marijuana Reform Bill Of 2021 (Marijuana Moment)

• Could Medical Cannabis Help with the Treatment of Movement Disorders? (Canex)

• Latest Canadian cannabis recalls include melting vape pens, moldy bud (Marijuana Business Daily)

• Virginia Marijuana Legalization Bill Approved By Senate Committee, With Home Cultivation Provisions Intact (Marijuana Moment)

• “Game changer” for the sector: First cannabis company expected to list on LSE next month (Cannabis Health News)

• Police Find 1st 'Cannabis Factory' In London's Financial District, Destroy 826 Plants (NPR)

• Hash landing: New Zealand police ditch annual helicopter hunt for cannabis dens (The Guardian)

• Phytol cited as potentially dangerous cannabis vape ingredient (Marijuana Business Daily)

• Study: Cannabis Use Associated with Reduced Alcohol Intake Among Treatment-Seeking Drinkers (NORML)

• Research establishes antibiotic potential for cannabis molecule (ScienceDaily)

• Women who use cannabis may have harder time conceiving (Healio)

• How Some THC Is Legal — For Now (Rolling Stone)

Magic Mushrooms

• Florida Lawmaker Introducing Psilocybin Mushroom Legalization (Forbes)

• Unique magic mushroom microdosing study to begin in Australia (New Atlas)

• How Mixing Mushrooms and MDMA Affects Your Body and Brain (VICE)

• Patient hopes Canada will introduce regulations for treatment with 'magic mushrooms' (CTV News)

• BC Craft Supply Co Announces Letter of Intent with Psilocybin Research and Development Company Ava Pathways (Globe Newswire)

MDMA

• MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD (Psilocybin Alpha)

Ayahuasca

• Insight into Ayahuasca’s Antidepressant Effects (Psychedelic Science Review)

5-MeO-DMT

• New Toad Venom Compound Synthesized for Clinical Use: 5-MeO-DMT Succinate (Psychedelic Science Review)

Synthetic Cannabinoids

• NCSA: Synthetic cannabis a cause for concern (Loop Barbados)

Ketamine

• Ketamine Clinicians Publish Ethical Guidelines to Raise Treatment Standards (Lucid News)

• Colorado officials resume review of ketamine program after Elijah McClain's death (CNN)

• PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorders (Psilocybin Alpha)

Miscellaneous

• Icelandic Government Proposes Drug Decriminalisation (The Reykjavik Grapevine)

• Peter Thiel-backed psychedelics start-up targets schizophrenia ahead of IPO (CNBC)

• Psychedelic Therapy Schools Are Popping Up Like Mushrooms (Bloomberg)

• The Biden Administration and Drug Policy: Expectation Versus Reality (Filter)

• North American Psychedelics Index Published: Which Companies Will Be in the First Psychedelic ETF? (Psilocybin Alpha)

• A New Supreme Court RFRA Ruling May Be a Boon to Psychedelic Religions (Chacruna)

• Senator wants to 'lock in' 2020 drug laws (Idaho Press)

• NeonMind Lists on the Frankfurt Stock Exchange (Psilocybin Alpha)

• Is Psychedelic Medicine the Antidote to Anti-Black White Racism in the US? (Chacruna)

• The Therapeutic Potential of Psychedelics and Nature Explored in New Study (Lucid News)

• Psychedelic Authoritarianism Harm Reduction: “QAnon Shaman” Edition (Psymposia)

• Here’s What’s Missing From Conversations About Psychedelic Integration (DoubleBlind)

• Attorney General Merrick Garland a Disheartening Prospect (Filter)

• Dopamine Release and Duration of Action: Rules of Thumb to Predict Addictive Potential of Phenethylamines (Spirit Pharmacist)

• Ergot in Canada: A Lost Tradition? (Chacruna)

• BetterLife Pharma Is Developing Second Generation Psychedelics: Drugs That Leave Out The Trip (Forbes)

• Former Defence Force chief Chris Barrie supports increased accessibility of psychedelic drugs (The Canberra Times)

• Could Biden Make His Country’s Global Drug War Even More Imperialist? (Filter)

• What Will The Psychedelics Space Look Like In 2021? Experts Weigh In (Yahoo! Finance)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.27.20

Cannabis

• Mexico’s Senate-Passed Marijuana Legalization Bill Moves To Chamber Of Deputies (Marijuana Moment)

• House Leadership Announces Vote On MORE Act To End Marijuana Prohibition Will Take Place Next Week (NORML)

• Marijuana Legalization Opponents Ask Courts To Overturn Voters’ Will In Several States (Marijuana Moment)

• Which States Are Poised to Advance Marijuana Legalization Reforms in 2021? (NORML)

• North Macedonia May Legalize Marijuana To Boost Tourism, Prime Minister Says (Marijuana Moment)

• New Jersey: Attorney General Issues Directive Halting Low-Level Marijuana Prosecutions (NORML)

• Republican Lawmakers And Celebrities Push Trump To Free Marijuana Prisoners Before Leaving Office (Marijuana Moment)

• Upcoming UN vote may be watershed moment for global medical cannabis – if only symbolic (Marijuana Business Daily)

• North Dakota: Gov. Burgum Issues Additional Pardons for Low-Level Marijuana Offenses (NORML)

• Connecticut Lawmakers Will Put Marijuana Legalization On The Ballot If Legislature Rejects Bill (Marijuana Moment)

• Federal Report: Marijuana Treatment Admissions Among Youth Decline Sharply in Legalization States (NORML)

• Number Of Banks Working With Marijuana Industry Continues To Drop Amid COVID, Federal Report Shows (Marijuana Moment)

LSD

• First Modern Dose-Response Study of LSD Confirms the Critical Role of the Serotonin 2A Receptor (Psychedelic Science Review)

• New doc 'My Psychedelic Love Story' remembers Timothy Leary (Fast Company)

Magic Mushrooms

• Psilocybin & migraine: First of its kind trial reports promising results (New Atlas)

• Two-Track Effort To Allow Psychedelic Mushrooms In Washington State Launches Amid Broader Drug Decrim Push (Marijuana Moment)

MDMA

• Research Suggests Past Antidepressant Usage Reduces Efficacy of MDMA-Assisted Psychotherapy for PTSD (Psilocybin Alpha)

• MDMA and Life Threatening Illnesses – A Commentary to Our Study (Psychedelic Support)

• Facilitating MDMA Therapy as a Treatment for PTSD with Marcela Ot’alora G (Chacruna)

Ayahuasca

• Two Arrested and Charged in Czech Republic for Distributing Ayahuasca (Lucid News)

• How Did Ayahuasca, Indigenous Diversity and Conservation Become Commodities in the Amazon? (Chacruna)

Ketamine

• Thailand's 'largest ketamine bust' turns out to be cleaning agent (BBC)

Datura

• Californian cave artists may have used hallucinogens, find reveals (Science Magazine)

Miscellaneous

• Vancouver Just Voted to Decriminalize All Drugs (VICE)

• Peter Thiel backs Berlin start-up making psychedelics in $125 million round (CNBC)

• What Removing the “Hallucinations” from Psychedelics Means for Psychotherapy (DoubleBlind)

• The world's first psychedelics hotline could help you work through a trip (Inverse)

• These Four Former Pro Athletes Are Using Psychedelics To Heal Their Brain Injuries (Forbes)

• Oregon County Prosecutor Stops Drug Possession Cases Early Following Decriminalization Vote (Marijuana Moment)

• BBC Two Programme to Follow Psychedelics vs. Antidepressants Trial (Psilocybin Alpha)

• University of Bristol hands free drug testing kits to students (BBC)

• Another Aspect of Reality: Maria Nys Huxley’s Influence on Psychedelic History (Chacruna)

• Middle East Science Diplomacy Focused on Psychedelics Could Generate Peace Dividends (Psychedelics Today)

• Catching Up With the Psychedelic Entourage Effect-Part 1: How We Got Here (Psychedelic Science Review)

• Psychedelics show religion isn’t the only route to spirituality (Psyche)

• Yu Maeda: A Psychedelic Artist Blending Japanese and American Influences (Sam Woolfe)

• Why California’s Future Psychedelics Legislation Should Start with Decriminalization of All Drugs (Chacruna)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.